Generation Bio
Public companyUS1 field
Where it works
| Technology | ||
|---|---|---|
| NanotechnologyDeveloped cell-targeted lipid nanoparticles for siRNA; agreed to be acquired by XOMA Royalty. | Developed cell-targeted lipid nanoparticles for siRNA; agreed to be acquired by XOMA Royalty. | sec.gov |
Events
| Date | Event | ||
|---|---|---|---|
| Dec 15, 2025 | XOMA Royalty agrees to acquire Generation Biosec.gov· Deal· Nanotechnology | Nanotechnology | Deal |
About
- Source
- sec.gov (filing, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | Generation BioCompany in Nanotechnology: Joined a field, Developed cell-targeted lipid nanoparticles for siRNA; agreed to be acquired by XOMA Royalty. | seed | sec.gov |
| Sep 25, 2026 | Generation BioCompany: Added | seed | sec.gov |